Return to search results
Potassium phosphates
Potassium Phosphates is an intravenous prescription solution made by Cipla USA Inc., containing dibasic and monobasic potassium phosphate. It provides essential minerals like potassium and phosphate to treat deficiencies, administered via injection. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Potassium Phosphates is an intravenous prescription solution made by Cipla USA Inc., containing dibasic and monobasic potassium phosphate. It provides essential minerals like potassium and phosphate to treat deficiencies, administered via injection. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Potassium phosphates",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Potassium phosphates — ANDA 218343 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218343"
}
]
|
| identifier | ANDA218343 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-safety",
"fda",
"medications",
"pharmaceuticals"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Potassium phosphates |
